InflaRx has been granted a patent for compounds that modulate mammalian C5a receptor activity by directly binding to the receptor. The invention includes pharmaceutical compositions for treating diseases involving C5a receptor activation. GlobalData’s report on InflaRx gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on InflaRx, NSAID cancer drugs was a key innovation area identified from patents. InflaRx's grant share as of May 2024 was 30%. Grant share is based on the ratio of number of grants to total number of patents.
Modulating c5a receptor activity for treating diseases
A recently granted patent (Publication Number: US11999698B2) discloses a compound with a specific chemical formula (XXI) and various derivatives thereof. The compound can have different configurations, including where X is hydrogen or when it follows formula (XXIa). Additionally, the compound may also be represented by formula (I) or formula (XI), with further variations denoted by formulas (II), (IIIa), (IIIb), (IIIc), and (IIId). The patent also covers the presence of specific groups like C1, C2, and C3 within the compound structure, along with R8 being selected from chloro, C2-C4 alkyl, C1-C4 haloalkyl, or C1-C4 alkoxy.
Furthermore, the patent extends to include pharmaceutical compositions containing the disclosed compound along with a pharmaceutically acceptable carrier. The compound derivatives mentioned in the claims encompass a wide range of formulas such as (Ia), (XIa), (IIa), (IIIe), (IIIf), (IIIg), and (IIIh). Notably, the patent specifies that R8 in certain instances can be chloro, trifluoromethyl, or methoxy, indicating the versatility and potential applications of the compound in various pharmaceutical contexts.
To know more about GlobalData’s detailed insights on InflaRx, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
